November 14, 2016 / 12:32 PM / 10 months ago

BRIEF-Aralez pharmaceuticals new post-hoc analysis supports yosprala efficacy

Nov 14 (Reuters) - Aralez Pharmaceuticals Inc :

* Aralez pharmaceuticals -new post-hoc analysis supports yosprala efficacy and safety in previous heart attack patients who need daily aspirin therapy Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below